Nasreen Khalil

5.8k total citations · 1 hit paper
65 papers, 3.4k citations indexed

About

Nasreen Khalil is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Molecular Biology. According to data from OpenAlex, Nasreen Khalil has authored 65 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 55 papers in Pulmonary and Respiratory Medicine, 15 papers in Physiology and 8 papers in Molecular Biology. Recurrent topics in Nasreen Khalil's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (49 papers), Sarcoidosis and Beryllium Toxicity Research (14 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (13 papers). Nasreen Khalil is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (49 papers), Sarcoidosis and Beryllium Toxicity Research (14 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (13 papers). Nasreen Khalil collaborates with scholars based in Canada, United States and Australia. Nasreen Khalil's co-authors include Robert O’Connor, Helmut Unruh, Gang Chen, K C Flanders, Harry B. Greenberg, Arnold H. Greenberg, Ying Xu, Christopher J. Ryerson, Angela Kemp and Kathleen C. Flanders and has published in prestigious journals such as The Lancet, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Nasreen Khalil

63 papers receiving 3.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Increased Production and Immunohistochemical Localization of Transforming Growth Factor- α in Idiopathic Pulmonary Fibrosis

1991 437 citations Nasreen Khalil, Robert O’Connor et al. American Journal of Respiratory Cell and Molecular Biology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Nasreen Khalil Canada	30	2.1k	941	585	352	290	65	3.4k
Steven K. Huang United States	29	1.4k 0.7×	788 0.8×	300 0.5×	259 0.7×	265 0.9×	74	2.6k
Daniel J. Kass United States	26	1.7k 0.8×	693 0.7×	375 0.6×	377 1.1×	168 0.6×	77	2.6k
Joseph A. Lasky United States	39	2.7k 1.3×	1.4k 1.5×	592 1.0×	422 1.2×	449 1.5×	109	4.7k
Tadashi Kohyama Japan	34	1.1k 0.5×	875 0.9×	616 1.1×	497 1.4×	252 0.9×	76	3.1k
Carina Becerril Mexico	22	1.7k 0.8×	620 0.7×	365 0.6×	226 0.6×	223 0.8×	42	2.5k
Humberto E. Trejo Bittar United States	23	1.2k 0.6×	894 1.0×	332 0.6×	415 1.2×	316 1.1×	60	2.5k
Αrgyris Τzouvelekis Greece	29	2.1k 1.0×	659 0.7×	658 1.1×	171 0.5×	305 1.1×	94	2.9k
Ronald H. Goldstein United States	37	1.8k 0.8×	1.4k 1.5×	293 0.5×	280 0.8×	495 1.7×	101	4.1k
Kurt Hong United States	17	1.2k 0.5×	499 0.5×	784 1.3×	384 1.1×	524 1.8×	36	3.1k
C. Magnus Sköld Sweden	30	1.1k 0.5×	677 0.7×	750 1.3×	575 1.6×	230 0.8×	65	2.8k

Countries citing papers authored by Nasreen Khalil

Since Specialization

Citations

This map shows the geographic impact of Nasreen Khalil's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nasreen Khalil with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nasreen Khalil more than expected).

Fields of papers citing papers by Nasreen Khalil

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nasreen Khalil. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nasreen Khalil. The network helps show where Nasreen Khalil may publish in the future.

Co-authorship network of co-authors of Nasreen Khalil

This figure shows the co-authorship network connecting the top 25 collaborators of Nasreen Khalil. A scholar is included among the top collaborators of Nasreen Khalil based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nasreen Khalil. Nasreen Khalil is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Assayag, Deborah, Xiaoping Chen, Jolene H. Fisher, et al.. (2025). Particulate Matter Associations with Lung Function in Pulmonary Sarcoidosis. American Journal of Respiratory and Critical Care Medicine. 211(10). 1846–1854. 1 indexed citations

Khor, Yet H., Kerri A. Johannson, Veronica Marcoux, et al.. (2024). Epidemiology and Prognostic Significance of Cough in Fibrotic Interstitial Lung Disease. American Journal of Respiratory and Critical Care Medicine. 210(8). 1035–1044. 10 indexed citations

Mattos, Waldo, Nasreen Khalil, Lisa Spencer, et al.. (2024). Phase 2, Double-Blind, Placebo-controlled Trial of a c-Jun N-Terminal Kinase Inhibitor in Idiopathic Pulmonary Fibrosis. American Journal of Respiratory and Critical Care Medicine. 210(4). 435–443. 10 indexed citations

Zheng, Boyang, Alyson W. Wong, Deborah Assayag, et al.. (2023). Impact of Antigen Exposure on Outcomes and Treatment Response in Fibrotic Hypersensitivity Pneumonitis. CHEST Journal. 165(6). 1435–1443. 3 indexed citations

Marcoux, Veronica, Prosanta Mondal, Deborah Assayag, et al.. (2023). Treatment of rheumatoid arthritis-associated interstitial lung disease in a multi-center registry cohort. Journal of Thoracic Disease. 15(5). 2517–2527. 6 indexed citations

Zheng, Boyang, Nathan Hambly, Kerri A. Johannson, et al.. (2022). Clinical relevance of rheumatoid factor and anti‐citrullinated peptides in fibrotic interstitial lung disease. Respirology. 27(10). 854–862. 2 indexed citations

Khor, Yet H., Nicole Goh, Alyson W. Wong, et al.. (2022). Impact of Concomitant Medication Burden on Tolerability of Disease-targeted Therapy and Survival in Interstitial Lung Disease. Annals of the American Thoracic Society. 19(6). 962–970. 9 indexed citations

Khor, Yet H., Mohammed A. Farooqi, Nathan Hambly, et al.. (2022). Trajectories and Prognostic Significance of 6-Minute Walk Test Parameters in Fibrotic Interstitial Lung Disease. CHEST Journal. 163(2). 345–357. 7 indexed citations

Assayag, Deborah, Kerri A. Johannson, Charlene D. Fell, et al.. (2021). Treatment Initiation in Patients with Interstitial Lung Disease in Canada. Annals of the American Thoracic Society. 18(10). 1661–1668. 7 indexed citations

10.

Shapera, Shane, Christopher J. Ryerson, Deborah Assayag, et al.. (2021). Effect of continued antifibrotic therapy after forced vital capacity decline in patients with idiopathic pulmonary fibrosis; a real world multicenter cohort study. Respiratory Medicine. 191. 106722–106722. 6 indexed citations

11.

Sadatsafavi, Mohsen, Jolene H. Fisher, Julie Morisset, et al.. (2020). Costs of Workplace Productivity Loss in Patients with Connective Tissue Disease–associated Interstitial Lung Disease. Annals of the American Thoracic Society. 17(9). 1077–1084. 5 indexed citations

12.

Wong, Alyson W., Deborah Assayag, Kerri A. Johannson, et al.. (2020). Minimum important difference of the EQ-5D-5L and EQ-VAS in fibrotic interstitial lung disease. Thorax. 76(1). 37–43. 38 indexed citations

13.

Guler, Sabina A., et al.. (2019). Impact of Psychological Deficits and Pain on Physical Activity of Patients with Interstitial Lung Disease. Lung. 197(4). 415–425. 12 indexed citations

14.

Fisher, Jolene H., Martin Kolb, Kerri A. Johannson, et al.. (2019). Baseline characteristics and comorbidities in the CAnadian REgistry for Pulmonary Fibrosis. BMC Pulmonary Medicine. 19(1). 223–223. 53 indexed citations

15.

Sadatsafavi, Mohsen, Jolene H. Fisher, Julie Morisset, et al.. (2019). Costs of Workplace Productivity Loss in Patients With Fibrotic Interstitial Lung Disease. CHEST Journal. 156(5). 887–895. 15 indexed citations

16.

Guler, Sabina A., et al.. (2019). Functional ageing in fibrotic interstitial lung disease: the impact of frailty on adverse health outcomes. European Respiratory Journal. 55(1). 1900647–1900647. 35 indexed citations

17.

Ryerson, Christopher J., Charlene D. Fell, H. Manganas, et al.. (2016). The Canadian Registry for Pulmonary Fibrosis: Design and Rationale of a National Pulmonary Fibrosis Registry. Canadian Respiratory Journal. 2016. 1–7. 34 indexed citations

18.

Ryerson, Christopher J., Lana Hilling, Pat G. Camp, et al.. (2013). Pulmonary rehabilitation improves long-term outcomes in interstitial lung disease: A prospective cohort study. Respiratory Medicine. 108(1). 203–210. 115 indexed citations

19.

Khalil, Nasreen, Robert O’Connor, K C Flanders, & Helmut Unruh. (1996). TGF-β1, but Not TGF-β2 or TGF-β3, is Differentially Present in Epithelial Cells of Advanced Pulmonary Fibrosis: An Immunohistochemical Study. American Journal of Respiratory Cell and Molecular Biology. 14(2). 131–138. 268 indexed citations

20.

Khalil, Nasreen, Robert O’Connor, Helmut Unruh, et al.. (1991). Increased Production and Immunohistochemical Localization of Transforming Growth Factor- α in Idiopathic Pulmonary Fibrosis. American Journal of Respiratory Cell and Molecular Biology. 5(2). 155–162. 437 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact